MedTrace Logo

vBloc Now - Registry

NCT03434522 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2018-07-26

No results posted yet for this study

Summary

This is a prospective, observational, case series registry which will collect information pertaining to experiences and health economics in individuals implanted with vBloc Therapy who are conjunctively using a weight management program. Subjects will be followed for 12 months after implant.

Conditions

  • Obesity, Morbid

Interventions

DEVICE

vBloc Maestro Rechargeable System

vBloc therapy consists of a neuromodulation device that delivers intermittent, controllable electrical blocking algorithms, to the intra-abdominal vagus nerve for the treatment of obesity.

Sponsors & Collaborators

  • ReShape Lifesciences

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-27
Primary Completion
2019-02-01
Completion
2019-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03434522 on ClinicalTrials.gov